GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (NSE:THYROCARE) » Definitions » Other Operating Expense

Thyrocare Technologies (NSE:THYROCARE) Other Operating Expense : ₹3,612 Mil (TTM As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies Other Operating Expense?

Thyrocare Technologies's Other Operating Expense for the three months ended in Mar. 2025 was ₹938 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₹3,612 Mil.

Thyrocare Technologies's quarterly Other Operating Expense increased from Sep. 2024 (₹912 Mil) to Dec. 2024 (₹961 Mil) but then declined from Dec. 2024 (₹961 Mil) to Mar. 2025 (₹938 Mil).

Thyrocare Technologies's annual Other Operating Expense increased from Mar. 2023 (₹2,353 Mil) to Mar. 2024 (₹2,491 Mil) and increased from Mar. 2024 (₹2,491 Mil) to Mar. 2025 (₹3,612 Mil).


Thyrocare Technologies Other Operating Expense Historical Data

The historical data trend for Thyrocare Technologies's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies Other Operating Expense Chart

Thyrocare Technologies Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,523.50 1,778.10 2,352.90 2,490.90 3,611.70

Thyrocare Technologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 869.30 801.70 911.50 960.90 937.60

Thyrocare Technologies Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,612 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thyrocare Technologies Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Thyrocare Technologies Business Description

Traded in Other Exchanges
Address
D-37/3, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies Headlines

No Headlines